Enveric Biosciences Raises $3.1 Million in Warrant Exercise

Enveric Biosciences has closed the exercise of certain outstanding warrants, raising $3.1 million in gross proceeds. The warrants were originally issued in February and September 2025 with exercise prices of $36.00 and $10.98 per share, respectively. The shares issuable upon exercise are registered pursuant to effective registration statements. The company plans to use the proceeds for product development, working capital, and general corporate purposes.